×

Agios CEO: We have two medicines that will change lives

3:33 PM ET Mon, 5 Dec 2016

David Schenkein, Agios CEO, speaks to CNBC's Meg Tirrell about his company's pyruvate kinase deficiency drug, stock performance and innovation.